Theralase Technologies Inc.

TSXV:TLT.V

$0.22 CAD

$0.01 (4.76%)

Volume
221.41K
Average Volume
121.88K
Market Capitalization
$48.77M
P/E Ratio
-11.58
Dividend Yield
0.00%
Price Target
$
Year High
$0.38
Year Low
$0.14
Payout Ratio
$0.00
Current Ratio
$1.21

Industry, Sector & symbol

Stock Exchange Toronto Stock Exchange Ventures
CEO Mr. Roger John Dumoulin-White B.Sc., P.Eng.
Industry Medical - Devices
Sector Healthcare
Current Symbol TLT.V
CUSIP None
CIK None
Web https://www.theralase.com
Phone 416 699 5273
Currency CAD
Employees 14
Country CA

Liquidity

Debt-to-Equity Ratio 0.00
Payout Ratio 0.00
Current Ratio 1.21
Quick Ratio 0.77
Cash Ratio 0.29

Sales & Book Value

Annual Sales $1.07M
Price / Sales 52.98
Cash Flow -0.01
Price / Cash Flow -14.49
Price / Book 30.78

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Strong Sell
Rating Score(0-5) 1
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0208
Trailing P/E Ratio -11.58
PEG Ratio -5.73
P/E Growth -5.73
Net Income $-4.57M
Net Margin -478.72%
Pretax Margin -499.16%
Return on Equity -246.03%
Return on Assets -130.20%

Financials Score

AltmanZ Score -14.09
Piotroski Score 4.00
Working Capital 313.81K
Total Assets 3.38M
Ebit -4.38M
Market Cap 48.77M
Total Liabilities 1.73M

Poll Results

About Theralase Technologies Inc. (TSXV:TLT.V) Stock

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II for the treatment of Bacillus Calmette Guérin - Unresponsive Carcinoma In-Situ non-muscle invasive bladder cancer. Further, its product candidates include TLC-2000, a superpulsed and visible red laser technology accelerates healing by ... reducing pain and inflammation while staying below the Maximal Permissible Exposure limit for tissue, as well as related accessories. Additionally, it provides controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100. The company has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiology Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. It sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is based in Toronto, Canada.

Frequently Asked Questions

What is the current Theralase Technologies Inc. (TLT.V) stock price?

Theralase Technologies Inc.(TSXV:TLT.V) stock price is $0.22 in the last trading session. During the trading session, TLT.V stock reached the peak price of $0.38 while $0.14 was the lowest point it dropped to. The percentage change in TLT.V stock occurred in the recent session was 4.76% while the dollar amount for the price change in TLT.V stock was $0.01.

TLT.V's industry and sector of operation?

The TSXV listed TLT.V is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of TLT.V?

Mr. Roger John Dumoulin-White B.Sc., P.Eng. | President, Chief Executive Officer & Director
Ms. Kristina Hachey CPA | Chief Financial Officer & Director
Dr. Arkady Mandel DSc., M.D., Ph.D. | Chief Scientific Officer & Director
Mr. David M. Groves B.A | President of World Trade Division
Dr. Terry Ruch DVM | Equine Medical Consultant

How many employees does TLT.V have?

Number of TLT.V employees currently stands at 14. TLT.V operates from 41 Hollinger Road, Toronto, ON M4B 3G4, CA.

Link for TLT.V official website?

Official Website of TLT.V is: https://www.theralase.com

How do I contact TLT.V?

TLT.V could be contacted at phone #416 699 5273 and can also be accessed through its website. TLT.V operates from 41 Hollinger Road, Toronto, ON M4B 3G4, CA.

How many shares of TLT.V are traded daily?

The average number of TLT.V shares traded daily for last 3 months was 121.88K.

What is the market cap of TLT.V currently?

The market value of TLT.V currently stands at $48.77M with its latest stock price at $0.22